Skip to main content
← Science / Explained

SERIES: MYTHS READ AGAINST THE SCIENCE

The kidney risk runs through dehydration from severe GI symptoms

The Cascade

The Wegovy label includes a specific warning about acute kidney injury. The warning is tied to severe GI reactions (vomiting, diarrhea) and the loss of body fluid that follows them.

Severe nausea drops fluid intake; severe diarrhea increases fluid loss; the kidneys respond to the resulting drop in blood volume. The labeled warning centers on acute kidney injury due to volume depletion. The chain is GI side effects → dehydration → kidney stress.

The Margin

The label points to renal-function monitoring when patients report adverse reactions that could lead to volume depletion. Closer attention during severe vomiting or diarrhea is the practical protection.

What this means

References1 sources

How to read these sources

This article uses primary sources and reviews to separate mechanism, human evidence, and context.

Official LabelRegulator documents
Show 4 more source types
Human TrialStudies in people
ReviewExpert synthesis
MechanismCell and pathway logic
Public UpdateNews or announcements
  1. Official Label

    FDA-approved prescribing information (Wegovy)

    U.S. Food and Drug Administration / Novo Nordisk

    Novo Nordisk · 2026 WEGOVY (semaglutide) prescribing information: 5.5 Acute Kidney Injury Due to Volume Depletion Read source

    Used Here For

    Grounding the kidney-damage question in the approved label's acute kidney injury warning.

    Good For

    The FDA-approved facts on labeled kidney-related risk, usually tied to dehydration from GI side effects.

    Not For

    Diagnosing kidney injury or giving personal medical advice.

    FDA-approved labeling, DailyMed (National Library of Medicine), updated June 18, 2026